These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease. Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, Sohn YH, Lee PH. Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277 [Abstract] [Full Text] [Related]
10. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease. Pagonabarraga J, Gómez-Ansón B, Rotger R, Llebaria G, García-Sánchez C, Pascual-Sedano B, Gironell A, Delfino M, Ruscalleda J, Kulisevsky J. Dement Geriatr Cogn Disord; 2012 Oct; 34(5-6):312-8. PubMed ID: 23208306 [Abstract] [Full Text] [Related]
11. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study. Baschi R, Nicoletti A, Restivo V, Recca D, Zappia M, Monastero R. J Alzheimers Dis; 2018 Oct; 63(3):1015-1024. PubMed ID: 29710711 [Abstract] [Full Text] [Related]
15. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Kandiah N, Mak E, Ng A, Huang S, Au WL, Sitoh YY, Tan LC. Parkinsonism Relat Disord; 2013 Jul; 19(7):680-3. PubMed ID: 23623194 [Abstract] [Full Text] [Related]
20. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Ray NJ, Bradburn S, Murgatroyd C, Toseeb U, Mir P, Kountouriotis GK, Teipel SJ, Grothe MJ. Brain; 2018 Jan 01; 141(1):165-176. PubMed ID: 29228203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]